• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 07/21/14

    • 30-Day SEC Yield1

      1.84%
    • Total Net Assets

      $339.1M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2014
  • Portfolio Composition (%)
    as of 07/21/14

    • % of Net Assets
    • Stocks

      100.18
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.18
  • Download All HoldingsAll Holdings (%)as of 07/21/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    341,414
    34,574,99610.20
    Novartis Ag
    NVS US
    366,945
    32,507,6589.59
    Pfizer Inc
    PFE US
    811,865
    24,640,1037.27
    Merck & Co Inc
    MRK US
    324,933
    18,846,1145.56
    Sanofi
    SNY US
    325,259
    16,741,0814.94
    Novo Nordisk A/S
    NVO US
    361,763
    16,322,7474.81
    Glaxosmithkline Plc
    GSK US
    295,940
    15,800,2374.66
    Abbott Laboratories
    ABT US
    361,564
    15,613,7814.60
    Eli Lilly & Co
    LLY US
    243,191
    15,476,6754.56
    Bristol-Myers Squibb Co
    BMY US
    307,977
    15,182,4184.48
    Allergan Inc/United States
    AGN US
    88,631
    15,168,3094.47
    Teva Pharmaceutical Industries Ltd
    TEVA US
    278,233
    15,108,0524.45
    Actavis Plc
    ACT US
    68,234
    14,747,4144.35
    Astrazeneca Plc
    AZN US
    194,861
    14,616,5244.31
    Abbvie Inc
    ABBV US
    266,689
    14,515,2544.28
    Shire Plc
    SHPG US
    57,402
    14,511,2264.28
    Mckesson Corp
    MCK US
    58,934
    11,106,1123.27
    Valeant Pharmaceuticals International I
    VRX US
    82,591
    10,368,4743.06
    Perrigo Co
    PRGO US
    37,729
    5,700,4751.68
    Mylan Inc/Pa
    MYL US
    110,524
    5,679,8281.67
    Zoetis Inc
    ZTS US
    143,000
    4,697,5501.39
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    37,176
    2,551,7610.75
    Hospira Inc
    HSP US
    42,533
    2,146,6410.63
    Salix Pharmaceuticals Ltd
    SLXP US
    12,429
    1,617,5100.48
    Questcor Pharmaceuticals Inc
    QCOR US
    15,727
    1,490,1330.44
    Other/Cash
    -596,282-0.18
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.